Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants

Pediatrics

Volumn 128, Issue 6, 2011, Pages

  Ozdemir, Ramazan ^a   Erdeve, Omer ^a   Dizdar, Evrim Alyamac ^a   Oguz, Serife Suna ^a   Uras, Nurdan ^a   Saygan, Sibel ^a   Karabulut, Erdem ^b   Dilmen, Ugur ^a  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bronchopulmonary dysplasia; Clarithromycin; Premature infants; Ureaplasma urealyticum

Indexed keywords

CLARITHROMYCIN; PLACEBO;

ARTICLE; BACTERIUM CULTURE; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; UREAPLASMA INFECTION; UREAPLASMA UREALYTICUM; VERY LOW BIRTH WEIGHT;

EID: 83155182599     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1350     Document Type: Article

References (30)

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-1729 (Pubitemid 32578778)
2. Schelonka RL, Katz B, Waites KB, Benjamin DK. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J. 2005;24(12):1033-1039 (Pubitemid 43011055)
3. Mabanta CG, Pryhuber GS, Weinberg GA, Phelps DL. Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev. 2003;4(4):CD003744
4. Baier RJ, Loggins J, Kruger TE. Failure of erythromycin to eliminate airway colonization with Ureaplasma urealyticum in very low birth weight infants. BMC Pediatr. 2003;3:10
5. Sinha SK, Gupta S, Donn SM. Immediate respiratory management of the preterm infant. Semin Fetal Neonatal Med. 2008;13(1):24-29 (Pubitemid 350298986)
6. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen D. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr. 2011;158(4):549-554
7. Biernat-Sudolska M, Rojek-Zakrzewska D, Drzewiecki A, Lauterbach R. Antimicrobial susceptibility of Ureaplasma urealyticum and Ureaplasma parvum isolated from premature infants with respiratory disorders. Przegl Epidemiol. 2007;61(2):371-376
8. Statistical power calculators. DSS Research. Available at: www.dssresearch. com/toolkit/spcalc/power-a2.asp. Accessed May 4, 2009
9. Schelonka RL, Waites KB. Ureaplasma infection and neonatal lung disease. Semin Perinatol. 2007;31(1):2-9 (Pubitemid 46273657)
10. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18(4):757-789 (Pubitemid 41504514)
11. Volgmann T, Ohlinger R, Panzig B. Ureaplasma urealyticum: harmless commensal or underestimated enemy of human reproduction? A review. Arch Gynecol Obstet. 2005;273(3):133-139 (Pubitemid 41666958)
12. Kirchner L, Helmer H, Heinze G, et al. Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants. Eur J Obstet Gynecol Reprod Biol. 2007;134(1):44-50 (Pubitemid 47332818)
13. Viscardi RM, Hasday JD. Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence. Pediatr Res. 2009;65(5 pt 2):84-90
14. Grattard F, Soleihac B, De Barbeyrac B, Bebear C, Seffert P, Pozzetto B. Epidemiologic and molecular investigations of genital mycoplasmas from women and neonates at delivery. Pediatr Infect Dis J. 1995;14(10):853-858
15. Abele-Horn M, Peters J, Genzel-Boroviczeny O, Wolff C, Zimmermann A, Gottschling W. Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection. 1997;25(5):286-291 (Pubitemid 27423633)
16. Kafetzis DA, Skevaki CL, Skouteri V, et al. Maternal genital colonization with Ureaplasma urealyticum promotes preterm delivery: association of the respiratory colonization of premature infants with chronic lung disease and increased mortality. Clin Infect Dis. 2004;39(8):1113-1122 (Pubitemid 40169307)
17. Cassell GH, Waites KB, Crouse DT, et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very low birth weight infants. Lancet. 1988;2(8605): 240-245
18. Wang EE, Frayha H, Watts J, et al. Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J. 1988;7(8):547-551
19. Sánchez PJ, Regan JA. Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants. Pediatr Infect Dis J. 1988;7(8):542-546
20. Wang EE, Ohlsson A, Kellner JD. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis. J Pediatr. 1995; 127(4):640-644
21. Lyon AJ, McColm J, Middlemist L, Fergusson S, McIntosh N, Ross PW. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998;78(1):10-14
22. Jónsson B, Rylander M, Faxelius G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr. 1998;87(10):1079-1084 (Pubitemid 28476007)
23. Waites KB, Sims PJ, Crouse DT, et al. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J. 1994;13(4):287-293 (Pubitemid 24113359)
24. Renaudin H, Bebear C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin, and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis. 1990;9(11):838-841
25. Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect. 2010;16(11):1649-1655
26. Zhanel GG, Dueck M, Hoban DJ, et al. Review of macrolides and ketolides: focus on respiratory tract infections. Drugs. 2001;61(4):443-498 (Pubitemid 32368062)
27. Ballard HO, Shook LA, Bernard P, et al. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial. Pediatr Pulmonol. 2011;46(2):111-118
28. Zalewska-Kaszubska J, Gorska D. Antiinflammatory capabilities of macrolides. Pharmacol Res. 2001;44(6):451-454
29. Theron AJ, Feldman C, Anderson R. Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro. J Antimicrob Chemother. 2000;46(2):269-271 (Pubitemid 30639297)
30. Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope. 2000;110(1):126-131 (Pubitemid 30046658)